Statements (12)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:ATC_code
|
| gptkbp:activeIngredient |
gptkb:peginterferon_alfa-2a
|
| gptkbp:affiliatedWith |
gptkb:Immunostimulants
|
| gptkbp:ATC_level |
5
|
| gptkbp:ATC_prefix |
L03AA
|
| gptkbp:routeOfAdministration |
subcutaneous
|
| gptkbp:usedFor |
gptkb:chronic_hepatitis_C
chronic hepatitis B |
| gptkbp:WHOCC |
World Health Organization Collaborating Centre for Drug Statistics Methodology
|
| gptkbp:bfsParent |
gptkb:Granix
|
| gptkbp:bfsLayer |
8
|
| http://www.w3.org/2000/01/rdf-schema#label |
L03AA14
|